TickerFactsScreenerDevelopers

PDS Biotechnology Corp (PDSB) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $140.9K2013: $7.86M2014: $13.73M2015: $130.19M2016: $106.40M2017: $88.07M2018: $103.7K2019: $12.16M2020: $28.84M2021: $65.24M2022: $73.82M2023: $56.56M2024: $41.69M2025: $26.71M$26.71M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$26.71M-35.9%
2024$41.69M-26.3%
2023$56.56M-23.4%
2022$73.82M+13.1%
2021$65.24M+126.2%
2020$28.84M+137.1%
2019$12.16M+11628.4%
2018$103.7K-99.9%
2017$88.07M-17.2%
2016$106.40M-18.3%
2015$130.19M+848.3%
2014$13.73M+74.7%
2013$7.86M—
2011$140.9K—